Abstract
Objectives
This study aimed to examine changes in antidepressant use in an elderly population over a 2-year period and to determine which factors could predict these changes.
Methods
This longitudinal study was conducted in 8,061 French community-dwelling subjects aged 65 years and over. At each wave, data on antidepressant use and general health status were collected and depressive symptoms were evaluated using a standardized instrument. Logistic regression models were used to identify baseline predictors of subsequent changes in antidepressant use.
Results
Prevalence of antidepressant use increased from 7.0% at baseline to 8.6% at 2-year follow-up. Selective serotonin reuptake inhibitors (SSRI) accounted for the main part of this increase. Four percent of the baseline nonusers took antidepressants 2 years later. This change was significantly associated with female gender, older age, higher education level, elevated depressive symptoms at baseline, history of major depression, poor self-perceived health, high consumption of nonpsychotropic drugs and cognitive impairment (in particular dementia). Approximately 5% of the elderly population was treated with antidepressants at both examinations, and most of them reported using the same class of antidepressant. Antidepressant withdrawal occurred in only 30% of antidepressant users; we did not find any factor significantly associated with termination of antidepressant use.
Conclusion
In this large elderly population, the proportion of antidepressant users increased by 23% over a 2-year period. Increasing use was found in all age groups. Our data suggested that many elderly people are chronic users of antidepressants independently of their depression status.
Similar content being viewed by others
References
Paterniti S, Verdier-Taillefer MH, Dufouil C, Alperovitch A (2002) Depressive symptoms and cognitive decline in elderly people. Longitudinal study. Br J Psychiatry 181:406–410
Luber MP, Meyers BS, Williams-Russo PG, Hollenberg JP, DiDomenico TN, Charlson ME et al (2001) Depression and service utilization in elderly primary care patients. Am J Geriatr Psychiatry 9:169–176
Patten SB, Esposito E, Carter B (2007) Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiol Drug Saf 16:746–752
Fitch K, Molnar FJ, Power B, Wilkins D, Man-Son-Hing M (2005) Antidepressant use in older people: family physicians’ knowledge, attitudes, and practices. Can Fam Physician 51:80–81
Lawrenson RA, Tyrer F, Newson RB, Farmer RD (2000) The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord 59:149–157
Lechevallier-Michel N, Gautier-Bertrand M, Alperovitch A, Berr C, Belmin J, Legrain S et al (2005) Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study. Eur J Clin Pharmacol 60:813–819
Blazer DG, Hybels CF, Fillenbaum GG, Pieper CF (2005) Predictors of antidepressant use among older adults: have they changed over time? Am J Psychiatry 162:705–710
Dealberto MJ, Seeman T, McAvay GJ, Berkman L (1997) Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol 50:357–364
Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B (2001) Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol 57:419–425
3C Study Group (2003) Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 22:316–325
Lawton MP (1988) Scales to measure competence in everyday activities. Psychopharmacol Bull 24:609–614
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
Radloff LS, Teri L (1986) Use of the CES-D with older adults. Clin Gerontol 5:119–136
Berkman LF, Berkman CS, Kasl S, Freeman DH Jr, Leo L, Ostfeld AM et al (1986) Depressive symptoms in relation to physical health and functioning in the elderly. Am J Epidemiol 124:372–388
Hertzog C, Van Alstine J, Usala P et al (1990) Measurement properties of the Center for Epidemiological Studies Depression scales (CES-D) in older populations. Psychol Assess 2:64–72
Fuhrer R, Rouillon F (1989) La version française de l’échelle CES-D (Center for Epidemiologic Studies-Depression scale). Description et traduction de l’échelle d’auto-évaluation. Psychiatr Psychobiol 4:181–190
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33;quiz 34–57
Steffens DC, Krishnan KR, Crump C, Burke GL (2002) Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke 33:1636–1644
Observatoire National des Prescriptions (1998) Etude de la prescription et de la consommation des antidépresseurs en ambulatoire. AFSSAPS, Paris
Hemels ME, Koren G, Einarson TR (2002) Increased use of antidepressants in Canada: 1981–2000. Ann Pharmacother 36:1375–1379
Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivela SL, Isoaho R (2002) Psychotropics among the home-dwelling elderly–increasing trends. Int J Geriatr Psychiatry 17:874–883
Mamdani MM, Parikh SV, Austin PC, Upshur RE (2000) Use of antidepressants among elderly subjects: trends and contributing factors. Am J Psychiatry 157:360–367
Blazer DG, Hybels CF, Simonsick EM, Hanlon JT (2000) Marked differences in antidepressant use by race in an elderly community sample: 1986–1996. Am J Psychiatry 157:1089–1094
Sambamoorthi U, Olfson M, Walkup JT, Crystal S (2003) Diffusion of new generation antidepressant treatment among elderly diagnosed with depression. Med Care 41:180–194
Montagnier D, Barberger-Gateau P, Jacqmin-Gadda H, Dartigues JF, Rainfray M, Peres K et al (2006) Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: results from the Personnes Agees Quid Study. J Am Geriatr Soc 54:1839–1845
van Eijk ME, Bahri P, Dekker G, Herings RM, Porsius A, Avorn J et al (2000) Use of prevalence and incidence measures to describe age-related prescribing of antidepressants with and without anticholinergic effects. J Clin Epidemiol 53:645–651
Egberts AC, Leufkens HG, Hofman A, Hoes AW (1997) Incidence of antidepressant drug use in older adults and association with chronic diseases: the Rotterdam Study. Int Clin Psychopharmacol 12:217–223
Rosholm JU, Andersen M, Gram LF (2001) Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. Eur J Clin Pharmacol 56:923–929
Hansen DG, Sondergaard J, Vach W, Gram LF, Rosholm JU, Mortensen PB et al (2004) Socio-economic inequalities in first-time use of antidepressants: a population-based study. Eur J Clin Pharmacol 60:51–55
American Psychiatric Association (2000) Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 157:1–45
Alexopoulos GS (2005) Depression in the elderly. Lancet 365:1961–1970
Alexopoulos GS, Buckwalter K, Olin J, Martinez R, Wainscott C, Krishnan KR (2002) Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. Biol Psychiatry 52:543–558
Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D et al (1996) Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community. Arch Gen Psychiatry 53:175–182
Elderkin-Thompson V, Kumar A, Bilker WB, Dunkin JJ, Mintz J, Moberg PJ et al (2003) Neuropsychological deficits among patients with late-onset minor and major depression. Arch Clin Neuropsychol 18:529–549
Fuhrer R, Dufouil C, Dartigues JF (2003) Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study. J Am Geriatr Soc 51:1055–1063
Lockwood KA, Alexopoulos GS, van Gorp WG (2002) Executive dysfunction in geriatric depression. Am J Psychiatry 159:1119–1126
Blazer DG (2003) Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 58:249–265
Acknowledgements
The Three-City Study is conducted under a partnership agreement between the Institut National de la Santé et de la Recherche Médicale (INSERM), the Victor Segalen-Bordeaux II University, and Sanofi-Aventis. The Fondation pour la Recherche Médicale funded preparation and initiation of the study. The Three-City Study is also supported by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Conseils Régionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de données biologiques." The experiments comply with the current laws of the country in which they were performed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Soudry, A., Dufouil, C., Ritchie, K. et al. Factors associated with changes in antidepressant use in a community-dwelling elderly cohort: the Three-City Study. Eur J Clin Pharmacol 64, 51–59 (2008). https://doi.org/10.1007/s00228-007-0392-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-007-0392-3